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Abstract

Snake Venom is a highly modified form of saliva, contains hundreds of zootoxins,
necrotoxins, cytotoxins, neurotoxins, and mytotoxins, all of which are primarily made up of
mostly proteins, polypeptides, and other components such as enzymes, lipids, and
carbohydrates. Although snake venom is known for its harmful effects, it has also had a positive
impact in scientific discovery and medicine. Some toxins from snakes’ function to inhibit pain,
and this means they can be very effective analgesics. For instance, crotalphine is considered a
14-amino-acid-peptide that has a disulfide bond and shows analgesic properties through TRPA1
desensitization. This is the reason why snake venom peptides are at our center of interest; there
are a plethora of new compounds to discover. Venomous snakes represent a large pool of
potentially bioactive proteins, and despite recent computational studies and discovery efforts of
over 2200 sequences, most of the snake venom toxins’ functions are still uncharacterized.
Using RNA pooled from the venom gland tissues of our sample, we constructed a cDNA
library. In order to generate full-length transcripts, we used the SMARTTM technique for firststrand cDNA synthesis combined with duplex-specific nuclease enzyme from Kamchatka crab for
cDNA normalization. Five hundred plaques were successfully screened, and 50 of them were
sequenced. The plaques that we screened, amplified, and analyzed using agarose gel
electrophoresis and then sequenced mostly coded for ribosomal proteins. Crotamine, C-type
lectin (CLEC), phospholipase (PLA2), and serine Protease were the components we were able to
identify when we proceeded to annotate our 4 selected sequences with the venom-associated
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genes. Using predictive modeling, we determined specific locations, coding regions, variation
information, exons, introns, and functions.
Crotamine functions to inhibit pain, and this means it can be a very effective analgesic, it
is a cell-penetrating peptide and a suitable means for transporting macromolecules through cell
membranes. Proteins with C-type lectin possess functions such as cell-to-cell adhesion, immune
response to pathogens, and apoptosis and have also shown anticoagulant and procoagulant
properties. PLA2 enzymes can bind to an array of proteins and target various types of tissues
and organs, and they tend to cause myonecrosis and spastic hind-leg paralysis. Serine proteases
play important roles in the diagnosis of hemorrhagic or thrombotic problems, and they stay in
the human system for a clinically useful length of time.
The four identified components of the full-length-enriched cDNA of timber rattlesnake
(Crotalus horridus) venom and their biochemical properties show promising applications in the
field of pharmacology and medical sciences.
ix., 44 pages
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INTRODUCTION

Snakes possess a highly modified form of saliva generally known as venom. Their glands,
which are modified parotid salivary glands, store this venom in the alveoli. Upon release, they
secret an array of zootoxins, necrotoxins, cytotoxins, neurotoxins, and myotoxins, all of which
have building blocks of proteins, polypeptides, and other components such as enzymes, lipids,
and carbohydrates. Most snake venom toxins participate in envenomation through a diverse array
of bioactivities (Ojeda et al. 2017), such as bleeding, inflammation, and pain, as well as cytotoxic,
cardiotoxic, or neurotoxic effects. The functions of these components depend on an extensive
variety and positions of nucleotides and nucleoside triphosphates in the genetic sequence of
these components. Although comparative venom-gland transcriptomics have revealed several
harmful effects of snake venom—such as renal failure, toxins that induce defibrination
coagulopathy, and microangiopathic hemolytic anemia (Chippaux et al. 2009) —it has also had a
positive impact in scientific discovery and medicine. For example, the most famous example of
snake-derived medicine is captopril (Capoten), which was developed by Bristol Myers Squibb and
is now used as a generic medicine for treating hypertension and congestive heart failure. It is a
small-molecule inhibitor of the angiotensin-converting enzyme (ACE) and is derived from
bradykinin-potentiating peptides found in the venom of the South American snake Bothrops
jararaca. It has been very forthcoming in the development of molecular scalpels that play a major
role in elucidation of ion channel function, vasoconstriction, platelet aggregation, signal
transduction, blood pressure regulation, and much more (McCleary and Kini 2013). Thus, it has
provided insight into cardiovascular physiology and is now being used worldwide to treat
1

thrombosis, arthritis, cancer, and strokes. Despite recent computational studies and discovery
efforts of over 2200 sequences, most of the snake venom toxins’ functions are still
uncharacterized. Analyzing these venoms provides a more detailed understanding of venoms and
toxins’ mechanisms of actions and an array of new drug possibilities (Melani et al. 2015). This
project uses modern bioinformatics methods such as pre- and post-PCR (polymerase chain
reaction) techniques to further study, identify, and characterize snake venom components and
their functions.
In rattlesnakes, 4 venom motifs have been identified: neurotoxic Type A, synonymous to
the south; hemorrhagic and proteolytic Type B, synonymous to the north and parts of the
southeast; Type A + B synonymous to southwestern Arkansas and northern Louisiana; and finally
Type C, which is not as strong as the other venoms (Norris 2004). Multiple transcripts occur in
most genes, which can be as a result of alternative splicing, a variety of encoded protein
products that may be either similar, dissimilar, or may even possess functions that are entirely
different within and across species. Ultimately, the purpose of proteomics is to identify and
compare structure-function relationships of proteins across venoms of a number of species.
However, proteomics falls short when it comes to analysis on a molecular level, so we used a
combination of transcriptomics and proteomics for qualitative and quantitative assessments in
order to decrypt our data avalanche.
Whole transcriptome analysis is instrumental in the initial step to functional
characterization and gene annotation previously revealed by DNA sequencing; it identifies
cellular genetic networks and biological, physiological, and biochemical systems that are
2

instrumental to molecular evolutionary analysis and collations that result in libraries of fulllength-enriched cDNA, new gene discoveries. It is advantageous when dealing with organisms
that have no prior sequencing information. Methods used for setting up cDNA libraries come
with their own shortcomings (Gubler and Hoffman 1983). The premature stop of reverse
transcription leads to cDNA clones that are not full length, resulting in inadequate
representation of cDNA 5’ ends (Maruyama and Sugano 1994). Regular DNA methods are
dependent on methylation, which is often not efficient in conserving internal restriction sites
and cloning (McClelland et al. 1994). This is the reason for the SMARTTM method (switching
mechanism at the 5’ end of the RNA transcript) Zhu et al. (2001). It used to increase the length
of cDNA clones by mirroring reverse transcription and switching the template of Moloney
murine leukemia virus (MMLV) (Kulpa et al. 1997). The Sfil sites accommodate the 5’ and 3’ ends
of the first-strand DNA; the 5’end is hybridized to a modified oligo(dT) primer that has a SfilB
restriction site, and the 3’ end is hybridized to a modified oligo(dT) primer that has a SfilA
restriction site (Zhu et al. 2001). As the process progresses, the oligonucleotides that host the
oligo(dT) sequences at the 3’ end bind to the extending template tail of the C-rich cDNA for
reverse transcriptase. Enzymes switch templates when reverse transcriptase gets to the 5’ end
of the mRNA enzyme and continues to replicate up to the oligonucleotide end (Zhumabayeva et
al. 2001). The result is a complete 5’ end at the first-strand cDNA due to premature termination
of cDNA that do not possess a SfilA site (Chenchik et al. 1998). The disadvantage of this
technique is that it is not strand specific and it is only applicable to poly(A)+ RNA. on the plus
side, the advantages are: (I) anonymous mRNA sequencing can be used; (II) starting material as
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little as 50pg can be used: (III) there is improved coverage across transcripts; and (IV) there is a
high level of mappable reads. Due to its high versatility, this method is integrated into multiple
sequencing techniques.
Duplex-specific nuclease (DSN) is instrumental in the normalization of full-lengthenriched cDNA (Zhulidov et al. 2004). It minimizes the frequency of high-abundance transcripts
and balances transcript concentration levels in a cDNA component, leading to more effective
sequencing outputs and discovery of rare genes that may be transcribed at relatively small levels
or for functional screenings. Recently, a very effective normalization technique was developed.
It is normalization technique (DSN normalization), which is based on the unique properties of
duplex-specific nuclease (DSN) from Kamchatka crab (Bogdanova et al. 2008). DSN is stable at
high temperatures of about 60 - 65°C, which enables the effective removal of ds-DNA from
complex nucleic acids at hybridization temperatures. In this technique, the cDNA is denatured
and then rehybridized. There is more of a transition of abundant transcripts to the ds-form, and
the ss-cDNA fraction is equalized. Post rehybridization, DSN hydrolyzes ds-cDNA, but the sscDNA fraction does not change. PCR is used to amplify the latter and used for construction of
normalized cDNA libraries.
A high-throughput, computer-automated sequencing using the vintage Sanger method
is applied in sequencing of clones from the cDNA library. A single-stranded primer will anneal to
the denatured DNA template in a reaction tube also containing 4 deoxynucleoside triphosphates
(dNTPs) and dideoxyribonucleotides (ddNTPs). Since a number of snake venom peptides are
about 100 residues long, the Sanger sequencing of expressed sequence tags (ESTs) tends to
4

produce the complete DNA sequence of a peptide. The samples are then separated on a singlelane capillary gel that is scanned with a laser beam. The amount of sequences that are retrieved
is quite smaller than that generated by next-generation sequencing (NGS).
Today we are dealing with an explosion of DNA sequence data; there are a plethora of
“tools” available on the Web to predict homologies, such as BLAST (Basic Local Alignment Search
Tool), Benchling, Clustal Omega, EMBL-EBI (The European Bioinformatics Institute), ExPASy (the
Expert Protein Analysis System), RCSB (the Research Collaboratory for Structural Bioinformatics),
and SMART™. The tools are selected based on the type of questions to which one is trying to
find answers. Alignment, identity, similarity, and expectation value (E-value) can be retrieved
using these tools. Identity is the percentage of similar components in the comparing sequences.
Similarity accounts for a quantitative measurement of the number of components that align at
certain positions—for instance, a leucine–leucine pairing would be more similar than a leucine–
cytosine pairing. The sum of the sequence similarity with respect to the length of the query
sequence that matched the sequence that was found by the tool is known as score; therefore, a
high similarity and a longer stretch will result in a high score. The E-value is the expected
number of sequences that will have that similarity score from the result of a query in the
database. However, the disadvantage of using these tools is that not everything that is added to
databases is correct; anyone can upload their sequences, leaving room for erroneous
annotations. These types of errors become alive in the database because new homologous
sequences may adopt the errors, and even after these mistakes have been noticed and
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corrected, the erroneous ones will still be in some part of the database. Backtracing the source
of the annotation is the only way to be assured that the results are accurate.
Some toxins from snakes function to inhibit pain, and this means they can be very
effective analgesics. For instance, crotalphine is considered a 14-amino-acid peptide that has a
disulfide bond and shows analgesic properties through TRPA1 desensitization. This is the reason
why snake venom peptides are at our center of interest; there are a plethora of new compounds
to discover. We annotate the selected sequences with the venom-associated genes using
predictive modeling to determine their specific locations, coding regions, variation information,
exons, introns, and functions. Gene expression levels for the select genes are confirmed, and
finally, the gene product is produced.

6

MATERIALS AND METHODS

Venom Samples
The biological sample (venom gland) was extracted from 3 adult timber rattlesnake (Crotalus
horridus) that were captured in the wild and kept in controlled environmental conditions in the
laboratory. The snakes were fed mice once a week in order to maintain a healthy diet. In order
to obtain tissue with high levels of toxin expression, their venom glands were extracted 72 hours
after milking and at the time of milking. In 1974, it was confirmed that epithelial cells become
shorter and more quiescent when venom glands are full compared to when they are empty, and
they are larger and more active (De Lucca et al. 1974). The next step with the aim of isolating
the total RNA involved in placing and homogenizing the venom gland in TRI Reagent® solution.
The reagent solution is built up of guanidine thiocyanate and phenol in a monophasic solution
that restricts RNase activity and gives room to isolation of high yield and total RNA of high
quality. Once a high-quality total mRNA was obtained, an RNA isolation kit (QIAGEN, Tokyo,
Japan) was used to isolate the mRNA. 1.5% agarose/EtBr gel run in 1x TAE buffer is used to make
a confirmation on the integrity of the total RNA.
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cDNA Normalization
DSN enzyme is purified from the hepatopancreas of Kamchatka crab, and it is also
available commercially. After successfully synthesizing first-strand DNA at 98°C for 2 minutes,
we denatured the reaction mixture, which comprised 1000mg of cDNA, 4µl of 4x hybridization
buffer (20mM HEPES, pH 7.5, 2 M NaCl), and Milli-Q® water making a total volume of 16µl.
Then it was allowed to hybridize at 68°C for 6 hours. Then 5µl of DSN master buffer (100 mM
Tris–HCl pH 8.0, 10 mM MgCl2, 2 mM dithiothreitol) that was already at 68°C was added to the
cDNA samples for a 10-minute time span. Next, at 68°C for 20 minutes, three different
concentrations of the DSN enzyme (Table 1) (Evrogen , Russia) were added to the reaction
mixtures, which were rendered inactive by the addition of 10µl of 5 mM EDTA solution for 5
minutes at the same temperature and then placed on ice.

Table 1. Normalization using 3 different DSN enzyme concentrations.

DSN solution
1/20 DSN solution
(0.05U/µl)
1/40 DSN solution
(0.025U/µl)
1/80 DSN solution
(0.0125U/µl)
DSN master buffer

Tube 1
(1/20 DSN)
1 µl

Tube 2
(1/40 DSN)
-

Tube 3
(1/80 DSN)
-

Tube 4 (control)

-

1 µl

-

-

-

-

1 µl

-

-

-

-

1 µl
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-

cDNA Synthesis
A SMARTTM cDNA Library Construction Kit (BD Biosciences Clontech, San Jose, CA, USA)
was used for first-strand cDNA synthesis. For the samples, we used 1–3µl RNA samples (0.5 to
1µg of total RNA) in line with the manufacturer’s instruction. 1µl each of the BD Biosciences
oligonucleotides SMARTTM Oligo VI and CDS-3M that contained the SfilA and SfilB recognition
sequence were used (Figure 1).
cDNA amplification was done by long-distance PCR (QIAGEN, Tokyo, Japan); PCR Primer
M1 was used to amplify the first strand (Figure 1). The PCR master mix for all reaction tubes was
prepared, and it comprised of 80µl Milli-Q® water, 10µl of 10x Advantage 2 PCR buffer, 2µl OF
50X dNTP mixture (10mM each), 4µl of 5’ PCR Primer M1, 2µl of first-strand cDNA, and 2µl of
Advantage 2 polymerase mix. The SMARTTM provided guidelines for the optimal number of
thermal cycles in correspondence to a given amount of poly A+ RNA used in the first-strand
synthesis. Modifying the guidelines provided by SMARTTM, we initiated 21 cycles, and the
thermal cycler was preheated to 95°C. Thermal cycling; the Initial denaturation occurred at 95°C
for 1 minute. The other cycles were 95°C for 15 seconds, 66°C for 20 seconds, and 72°C for 3
minutes, and the final extensions at 66°C for 20 seconds; 72°C for 3 minutes were performed.
After amplification, cDNA purification was carried out using QIAquick PCR Purification Kit
(QIAGEN, Tokyo, Japan) with the aim of removing the excess primer, dNTPS, and salts. After the
purification step, and after precipitation with ethanol, the cDNA was dissolved in Milli-Q® water
to a final concentration at 100 ng/µl.

9

cDNA Amplification
Amplifying normalized cDNA and determining the optimal number of PCR cycles was
achieved with 40.5 µl of Milli-Q® water, 5µl of 10x PCR buffer, 1µl dNTP mix, 1.5µl of PCR
Primer-M1 (Figure 2), 1µl of normalized cDNA, and 1mL of PCR mix. Next, it was put through the
process of cycling at settings: 95°C for 1 minute for initial denaturation 17 PCR cycles at 95°C for
15 seconds, 66°C for 20 seconds, and 72°C for 3 minutes 10µl was collected from the 17-cycle
PCR control tube into a clean tube for further PCR cycling, collecting 12-µl aliquots after 18, 20,
22, 24 and 26 PCR cycles. 5µl of the aliquots of each PCR was analyzed after 17, 19, 21, 23, and
25 cycles alongside of 1kb DNA size markers on a 1.5% agarose/EtBr, run in 1x TAE buffer, to
confirm the optimal number of cycles required for amplification.
When the optimal number of cycles were acquired, 2µl of normalized cDNA was diluted
into 20µl of Milli-Q® water. For the second PCR amplification, the following steps were followed:
80µl of Milli-Q® water, 10µl of 10x PCR buffer, 2µl of diluted normalized cDNA and 2µl of dNTP
mix (10mM), 4µl of PCR Primer M2 (Figure 2), and 2µl of diluted normalized cDNA and 2µl of
polymerase mixture. Then it underwent PCR cycling using the following settings: initial
denaturation at 95°C for 1 minute; 12 PCR cycles at 95°C for 15 seconds; 64°C for 20 seconds;
and heat at 72°C for 3 minutes; and a final extension at 64°C for 15 seconds and 72°C for 3
minutes. After the cDNA amplification cycles were completed, 5µl of each sample were loaded
on a 1.5% (w/v) agarose/EtBr gel in 1x TAE buffer and electrophoresed to observe the PCR
quality from the characteristic gel profile.

10

Figure 1. List of Primers used for first-strand cDNA synthesis.

5’-oligonucleotide adapter for the template switching reaction:
5’- AAGCAGTGGTATCAACGCAGAGTGGCCATTAC GGCCGGG-3’

CDS-3M adapter:
5’-AAGCAGTGGTATCAACGCAGAGTGGCCGAGGCG GCC(T)20 VN-3’
(N=A, C, G, or T; primers V=A, G, OR C)

Figure 2. List of primers used for cDNA amplification:

PCR Primer M1 (10mM): 5’ – AAGCAGTGGTATCAACGCAGAGT-3’
PCR Primer M2 (10mM): 5’ – AAGCAGTGGTATCAACGCAG-3’

Sfil Digestion and Ligation of cDNA to λTriplEx2 Vector
The λTriplEx2 Vector used was provided by Clontech Laboratories, Inc. (now Takara Bio
USA, Inc.) (SMARTTM cDNA Library Construction Kit). Normalized cDNA samples digested by Sfil
were ligated and packaged into a λTriplEx2 vector. Three separate ligation reactions with
different ratios of cDNA to phage vector were set up with varying ratios of cDNA to phage vector
(Table 2). The reaction tube was incubated at 16°C overnight. The packaging protocol was done
according to the manufacturer’s instructions, and MaxPlaxTM Lambda Packaging Extracts for
λTriplEx2 reactions with an efficiency of 3 x 109 pfu/µg DNA were used.
11

Titrating the Unamplified Library
The titrating protocol was instrumental in determining the titer of the unamplified
library and the percentage of recombinant clones. The primary stock plate was prepared by
recovering frozen cells of Escherichia coli XL1-Blue competent cells provided with the SMARTTM
cDNA Library Construction Kit (BD Biosciences Clontech) and streaking about 5µl of it on an
LB/tet plate. The stock plate was then incubated overnight at 37°C.
To ascertain the titer of unamplified library from the initial prepared culture, a single
isolated colony was selected from the working stock plate and used to inoculate 15ml of
LB/MgSO4/maltose broth in a 50-ml test tube. It was then incubated overnight at 37°C while
vibrating at 140 rpm until the culture’s OD600 reached 2.0. Dilutions of the packaging extracts at
1:5, 1:10, 1:15, and 1:20 were made in 1X Lambda dilution buffer (NaCl, MgSO4·7H2O Tris-HCI
[pH 7.5]). 1µl of the ligation reaction was added to E. coli XL1-Blue competent cells overnight;
the phage was allowed to adsorb at 37°C for 15 minutes. In the next step, 2ml of melted
LB/MgSO4 agar was added and poured onto LB/MgSO4 plates. The cooled plates were incubated
at 37°C for 18 hours. The titer of the phage was calculated using the formula

(

𝑝𝑝𝑝𝑝𝑝𝑝
𝑚𝑚𝑚𝑚

=

l
ml

𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 𝑜𝑜𝑜𝑜 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑥𝑥 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝑥𝑥 103 µ
µl of diluted phage plated

) .

In order to identify the percentage of recombinant clones, blue-white screening was
applied using E. coli XL1-Blue. The lacZ α-complementation was then used to identify a phage-
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containing insert on a medium with IPTG and X-Gal added to top agar, and this was achieved by
embedding the λTriplEx2 vector cloning site in the coding sequence for LacZ.

Library Amplification and Titrating
200µl of the overnight bacteria culture and 50µl of 1:20 diluted lysate were added to 20
separate 10-ml tubes. It was incubated at 37°C for 15 minutes. Next, 5ml of melted LB/MgSO4
soft top agar is added and poured into the LB/MgSO4 plates. The top agar hardened for 10
minutes. The plates were inverted and placed in the incubator at 37°C for 18 hours. After the
incubation, 12ml of 1X Lambda dilution buffer was added to each plate and kept at 4°C
overnight. Plates were placed on a shaker at 50rpm for an hour at room temperature, prior to
pooling 1X Lambda dilution buffer on each plate we poured λ phage lysate into a sterile 50-ml
screw-cap tube. 10ml of chloroform was added and then vortexed for 2 minutes and centrifuged
at 7000 rpm for 10 minutes to clear the phage lysate of cell debris. The supernatant was then
collected and stored at 4°C.
In order to determine the titer of the amplified library of the prepared dilution’s lysate,
10µl of the lysate (Dilution 1 = 1:100) was added into 1ml of the 1X Lambda dilution buffer. 10µl
of the lysate (Dilution 2 = 1:10000) was added into the second tube. Next, 4 10-ml tubes using
the overnight culture and Phage Dilution 2 were prepared (Table 3), and 5ml of melted
LB/MgSO4 soft top agar was added and poured into LB/MgSO4 agar plates. The top agar
hardened for 10 minutes. The plates were inverted and placed in the incubator at 37°C for 18
13

hours. After the incubation, plaques were counted and the titer was calculated using the
formula ( 𝑝𝑝𝑝𝑝𝑝𝑝/𝑚𝑚𝑚𝑚 =

l
ml

𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 𝑜𝑜𝑜𝑜 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑥𝑥 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝑥𝑥 103 µ
µl of diluted phage plated

).

Table 2. Ligations using 3 different ratios of cDNA to phage vector.

Component
cDNA
Vector (500 ng/µl)
10X ligation buffer
ATP (10mM)
T4 DNA ligase
Deionized H2O*
Total volume (µl)

1st ligation (µl)
0.5
1.0
0.5
0.5
0.5
2.0
5.0

2nd ligation (µl)
1.0
1.0
0.5
0.5
0.5
1.5
5.0

3rd ligation (µl)
1.5
1.0
0.5
0.5
0.5
1.0
5.0

Table 3. Plating dilutions for titrating an amplified library

1X lambda tube
1
2
3
4 (control)

1X lambda dilution
buffer
100 µl
100 µl
100 µl
100 µl

bacterial overnight
culture
200 µl
200 µl
200 µl
200 µl
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phage dilution 2
5µl
10µl
20µl
0µl

Screening and Sequencing
Plaques from the plates that were previously prepared to determine titer of amplified
library were randomly selected and assigned an identification number. The pipette was used to
carefully transfer the plaque into PCR tubes containing MgCl, dNTP, Taq polymerase, PCR buffer,
Primer F (5’ primer), Primer R (3’ primer) and Milli-Q® water. PCR protocols were initiated as
follows: initial denaturation at 95°C for 5 minutes, 29°C for 20 seconds, 60°C for 20 seconds,
72°C for 30 seconds, and a final extension of 72°C for 2 minutes. Using another tip, we gently
touched the same plaque and then touched the LB/MgSO4 agar plate with solidified LB/MgSO4
top agar and overnight culture in quadrant that matched the assigned identification number. It
was then incubated at 37°C for 18 hours.
Agarose gel electrophoresis was used to ascertain the integrity of the amplified cDNA
transcripts, and the promising VG clones that showed bands based on size separation were sent
off to BD Biosciences for sequencing.

Data Analysis
The sequencing results received-VG 4 – Crotamine, VG 36 – C-Type Lectin, VG 141 –
Phospholipase A2, and VG 172 – Serine Protease—were uploaded to the Basic Local Alignment
Search Tool (BLAST) to annotate the selected sequences with the venom-associated genes. The
nucleotide BLAST identified regions of similarities between biological sequences (alignments),
the identity, the expectation value (E-value) of the query sequence, and the sum of the
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sequence similarities with respect to the length of the query sequence that matched the
sequence that was found (score). The matching sequences with the highest similarities and the
longest stretch and with the lowest E-values were then selected. The sequence was identified as
well as the start and stop codons and the poly(A) tail region.
After identifying the nucleotide sequences from the BLAST search, the translation tool
ExPASy, which allows the translation of a nucleotide (DNA/RNA) sequence to a protein
sequence, was used to retrieve the encoded protein sequences from the nucleotide sequence.
Next, the amino acids sequence, frequencies, and net charge were retrieved from the Benchling
cloud .
Gene expression (Real time quantitative PCR)
In order to address issue of the best time to collect tissue for library construction, real time
quantitative PCR was used to measure the relative abundance of crotamine mRNA levels from
tissue taken prior to venom collection (n=3) and those taken 72 hours later (n=3). Reverse
transcriptase reactions were conducted on all six samples, followed by amplification of
crotamine cDNA using the following primers:
Figure 3. List of primers used for real-time PCR (reverse transcriptase reaction):

Forward primer – 5’ CCCAAAACCAGTCTCACCAT 3’
Reverse primer – 5’ TTTGCAGCATTTTCCTTTCC 3’
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SYBR green intercalating dye was used as the fluorescent reporter for quantification. Abundance
of crotamine cDNA in each sample was cross referenced with a standard curve of amplification
for crotamine levels were compared using Student’s t-test
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RESULTS

PRE/POST PCR
The adult timber rattlesnake was captured in northeast Alabama. It was 97 cm long and
weighed 800 g. It was kept in controlled conditions in the laboratory for 6 months. The venom
gland was extracted after 72 hours, 24 hours after milking, and at the time of milking. The
collection apparatus used for milking was assembled using rubber gloves, a glass funnel and a
50-ml tube. The venom was collected in the amount of 1.1 ml by making the snake bite into the
rubber gloves; then it was preserved at -70°C. Next, the snake was anesthetized and sacrificed
by decapitation, and 600 mg of venom glands were successfully extracted. These venom gland
tissues were kept in a 50-ml tube and homogenized in TRI Reagent® solution using tissue
blender frozen at -70°C.
Following TRI Reagent® protocol, extraction of total RNA from homogenized tissues was
carried out; agarose gel electrophoresis was then used to confirm its integrity. mRNA was
isolated from the total RNA using the mRNA isolation kit. Using the spectrometer, the
concentration of mRNA was found to be 866ng/µl. First-strand cDNA was synthesized from 2µl
of mRNA using the SMARTTM cDNA Library Construction Kit, and then it was amplified with LD
PCR and confirmed with agarose gel electrophoresis. The amplified cDNA was then purified and
subjected to DSN normalization. The optimal concentration of DSN enzyme for normalization
was observed to be 0,025U/µl. Normalization revealed that the optimal number of cycles for
PCR is 24. The normalized and purified cDNA was Sfil digested and packaged into a vector. Titer
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of unamplified library was 1X10^6PFU, and after performing blue-white screening, the
percentage of recombinant clones was 100%. Calculation showed the amplified library titer was
1X10^8pfu.
Random selections from 500 plaques were screened, amplified, and analyzed using
agarose gel electrophoresis. 50 of them were selected and sequenced. These sequences were
analyzed using BLAST, and the closest similar match was identified for each one of them. A good
number of the sequences represented transcripts for ribosomal proteins. From the 50 selected
sequences, we further selected 4 sequences that stood out due to their integrity on the agarose
gel and their pharmacological benefits.

DATA ANALYSIS
From the BLAST, search, we confirmed the sequence IDs by finding the matching
sequence with high BLAST percentage and the lowest E-values, and the sequences identified
were VG 4 – Crotamine, VG 36 – C-Type Lectin, VG 141 – Phospholipase A2, and VG 172 – Serine
Protease (Table 4).
These four venom components were translated from nucleotide sequences to protein
sequences with ExPASy and from these 4 protein sequences, we selected VG 4 – Crotamine for
gene expression (Figures 3, 4, 5, 6). The biochemical properties, frequencies, and net charge of
the amino acid sequence for crotamine were identified with Benchling (Figure 7).

19

Table 4. BLAST search to identify transcripts of 4 selected sequences from normalized libraries
(BLAST)

cDNA

Closest

Score

Length

Expect ratio

Identities

Gaps

412 bits (456)

358

7e-111

279/313

0/313(0%)

match/sequence ID
VG 4

C. horridus crotamine
mRNA,

(89%)

ID: JF895768.1

VG 36

C.horridus C-type lectin

696 bits (771)

697

0.0

2 mRNA,

534/630

6/630 (0%)

(85%)

ID: HQ414090.1

VG 141

C. horridus

720 bits (798)

445

0.0

phospholipase A2

428/445

3/445 (0%)

(96%)

mRNA,
ID: GQ168369.1
VG 172

C. horridus_SVSP-5

858 bits (951)

2539

serine protease mRNA,

0.0

822/1028
(80%)

ID: MF974519.1
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35/1028(3%)

Figure 4. DNA sequences and translated protein sequences for crotamine (ExPASy).
This figure shows the DNA sequences for 4 component of the timber rattlesnake (C. horridus)
venom and their corresponding translated protein sequences, showing the start and stop
proteins, Poly(A) signals and Poly(A) tails for VG 4 – C. horridus_crotamine

cggccggaaaaatttggcccaaaaccagtctcacc ATG aaa atc ctt tat ctg
M
K
I
L
Y
L
ctg ttc gct ttt ctt ttc ctt gct ttc ctg tct gaa cca gga aat gcc tat aaa
L
F
A
F
L
F
L
A
F
L
S
E
P
G
N
A
Y
K
cgg ggt ctt aaa aaa gga gga ccc tgt ttt ccc aaa acc gaa ata tgt ctt cct
R
G
L
K
K
G
G
P
C
F
P
K
T
E
I
C
L
P
cca tct tct gat ttt gga aaa
P
S
S
D
F
G
K

agg gac tgt caa tgg aaa gga aaa tgc tgc aaa
R
D
C
Q
W
K
G
K
C
C
K

aag gaa agg gaa aat aat gcc ttc ccc atc TAG gaccagggatatcttcaaaatttggcca
K
E
R
E
N
N
A
F
P
I
*
aggacctgaaagggccccctgctatccctgtatctttcttt aaataaatcaaattgctaccc
Poly A Signal
aaaaaaaaaaaaaaaaa
Poly A tail

Figure 5. DNA sequences and translated protein sequences for C-type lectin 2 (ExPASy).
This figure shows the DNA sequences for 4 component of the timber rattlesnake (C. horridus)
venom and their corresponding translated protein sequences, showing the start and stop
proteins, Poly(A) signals and Poly(A) tails for VG 36 – C. horridus_C-type lectin 2

cggccggaaagcaggggtttcaccgcaaaggggccgaggaaaaggaaaggaaaaaaaacc
atg ggg gga ttc ttc ttc ggg agt ttt ggt ttg ctg gcc ggg tcc ctc tcc ctg agg gaa
M

G

G

F

F

F

G

S

F

G

L

L

A

G

S

L

S

L

R

E

ACT gca gct gat tgc ccc tcg ggt ggg tct tcc tat gaa ggg ctt tgc tac aac ccc ttc
T

A

A

D

C

P

S

G

G

S

S

Y

E

G

L

C

Y

N

P

F

aat gac cca aaa acc ggg gat gat gca aaa aac ttc tgc cca caa cag cac aca ggg gga
N

D

P

K

T

G

D

D

A

K

N

F

C

P

Q

Q

H

T

G

G

ctt ttg gtc tcc tcc cac agc act gaa aaa gca aat ttt ggg agc aag ctg gcc ttc caa
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F
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T

F

G

Q

R

I

F

W

I

G

L

T
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N

K

C

T

W
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K
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V
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E

F

R

A
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cccccccccagacccccccactttgctcaagggatgctctctggggcggaatcgggttctgcggctccggaggga
ccaaaaggtccaataaattctgcctaccttgaaaaaaaaaaaaaa
Poly A Signal

Poly A tail

Figure 6. DNA sequences and translated protein sequences for phospholipase A2 (ExPASy).
This figure shows the DNA sequences for 4 component of the timber rattlesnake (C. horridus)
venom and their corresponding translated protein sequences, showing the start and stop
proteins, Poly(A) signals and Poly(A) tails for VG 141 – C. horridus_phospholipase A2

cggccggaaagcaggggtatcaacgcaaagtcattacggccgggggcagaggagcaaagggagcctgccaggtgtgaa
tctttgccattttcccctgcctggtttctcctgatccttgcctacaaattatccttgacttacaaccgtttgtttagt
gaccgttctaagggcctttttccaaacttcaccagcggaggcaattaacggggtctgcttattcccaagtctggattc
gggagg

ATG agg act ctc tgg ata ggg gcc gta ttg ctg ctg ggc gtc aag ggg agc ctg ggg caa
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R

T

L
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I

G

A
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L

L

L

G
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F

E

M

M

I

M

E

G

A

K

K

S

G

L

L
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Y

S

A

Y
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G

C

Y

C

G

W

G

G

H

G

R

P
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D
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D

R

C

C
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F
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C
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Y

D
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aataataaacaggtgccacttttgcactcaaaaaaaaaaaaaaaaa
Poly A Signal

Poly A tail

Figure 7. DNA sequences and translated protein sequences for serine protease (ExPASy).
This figure shows the DNA sequences for 4 component of the timber rattlesnake (C. horridus)
venom and their corresponding translated protein sequences, showing the start and stop
proteins, Poly(A) signals and Poly(A) tails for VG 172 – C. horridus_SVSP-5 serine protease.

tttcggaagggccccttggttttgttcccggggatccgcccttagggcggggggggaacttcgggattcattctgccag
tgtcccaaattgttggccccccacctgtttattttgatcaaataaagggctttggatcaaaaaacccccgcttggttta
tctaataaaactgatacggaatctcatttttaagttgggaacgggaatcttacaaacaaacggcttaccgggcaaagct
gaagtt
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Poly A Signal

Poly A tail

tttagcccgatttctcctacacaatattataaatgcgccc

Table 5. Biochemical properties for Crotamine, C-type lectin 2, Phospholipase A2, Serine
protease (Benchling).

Position

Molecular
weight

Isoelectric
point

pH range

Net charge

Crotamine

1-70 AAs

7991.41 Da

9.40

4 – 10

11.27 – -4.57

C-type lectin 2

1-146 AAs

16232.43 Da

9.41

4 – 10

18.04 – -6.49

Phospholipase A2

1-137 AAs

15320.45 Da

7.92

4 – 10

12.37 – -18.89

Serine protease

1-1209 AAs

22645.34 Da

9.84

4 – 10

26.38 – -2.47
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Figure 8 shows Real-time PCR amplification for C. horridus that resulted in the amplification of
198 bp amplicon. Levels were determined to be 18.5 fg/1 ug total RNA for venom glands
collected at 0 hr post venom collection; Levels were determined to be 69.5 fg/1 ug total RNA for
venom glands collected at 72 hr post venom collection. ( p= 0.12)
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DISSCUSSION

Since the times of ancient Greece, substances have been extracted from snakes and
used as medicinal remedies. The discovery of snake venom proteins and enzymatic toxins has
had a large part to play in the technological development of proteomics and transcriptomics.
Snake venom, which is a highly modified form of saliva, is made of several proteins and peptides
that are pharmacologically active and specialized in various biological processes. Due to its
analgesic properties, snake venom components have been applied in research and medicine
(Stocker 1990). In this study, we were able to create a cDNA library, annotate our resulting
sequences, and identify 4 of several venom component proteins that can possibly be used as
therapeutic agents. They are: crotamine, phospholipase A2, C-type lectin and serine protease.

Crotamine
In our study, we confirmed crotamine in our cDNA library; its biochemical properties
include 1-70 AAs in position, a molecular weight of 7991.41Da, isoelectric Point (pI) 9.40, pH
range of 4 to 10, and net charge range of 11.27 to -4.57. Real-time PCR amplification for C.
horridus that resulted in the amplification of 198 bp amplicon. Levels were determined to be
18.5 fg/1 ug total RNA for venom glands collected at 0 hr post venom collection; Levels were
determined to be 69.5 fg/1 ug total RNA for venom glands collected at 72 hr post venom
collection. Data suggests that crotamine expression was elevated at 72 hours post venom
collection, however this was not significantly higher than at 0 hour ( p= 0.12). This small, basic
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myotoxin was one of the identified protein components, and it was the first gene to ever be
mapped on a snake chromosome (Oguiura et al. 2005). It a cationic polypeptide with high
affinity for negatively charged excitable membranes (Santoro et al. 1999). It is made up of short
polypeptides about 42 residues long with 11 basic components (9 lysines, 6 cysteines, and 2
arginines) (Massey et al. 2012). There have been previous studies (Kerkis et al. 2004, Fusco et al.
2020) carried out on the crotamine extracted from the venom of the South American
rattlesnake C. durissus terrificus. Crotamine amino acid sequences were found to have high
similarities; they caused skeletal muscle contractions, which led to paralysis of the hind limbs of
mice through interaction with sodium channels on muscle cells (Oguiura et al. 2005). Nicastro et
al. (2003) used nuclear magnetic resonance (NMR) spectroscopy to show the structure of
crotamine. From their findings, the topology of crotamine was unlike anything previously seen in
active toxins that target ion channels. It comprised a short N-terminal alpha helix protein
formation and a small, antiparallel triple-stranded beta-sheet protein formation. Oguiura et al.
(2005) showed protein formations containing a ab1b2b3 topology arrangement; they found
identical disulfide bridges and structural fold conformations which are analogous to the human
beta-defensin family. Kerkis et al. (2004) found that crotamine specialized in proliferating
different types of cells from in vitro—such as murine embryonic stem cells, human primary
fibroblasts, lymphoblastic cells, and endothelial cells—to in vivo in cells that were isolated from
mice. Crotamine can be delivered to different cells because it forms a complex with plasmid
DNA. Its properties make it a cell-penetrating protein (CPP) comprising nuclear localization with
an ability to terminate active tumor cells (Hayashi et al. 2008). Crotamine being a CPP makes it a
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suitable means for transporting macromolecules through the cell membranes. All these
biochemical properties make it an effective means of achieving therapeutic routes in
pharmacology and medicine.
C-Type Lectin (CLEC)
We confirmed C-Type lectin in our cDNA library; its biochemical properties include 1-146
AAs in position, molecular weight of 16232.43 Da, isoelectric point (pI) 9.41, pH range of 4 to 10,
and a charge range of 18.04 to -6.49. Popular types of CLEC are galactose or mannose, usually
with homo- or heterodimer structures (Viala et al. 2015). CLEC is a protein domain that binds to
carbohydrate; it requires calcium to perform this binding. Generally, proteins with CLEC possess
functions such as cell-to-cell adhesion, an immune response to pathogens, and apoptosis (Cambi
and Figdor 2009). In recent studies, CLEC from Bothrops moojeni showed anticoagulant and
procoagulant properties; they are affected by platelet aggregation, insulin secretion, and
antibacterial activity (Barbosa et al. 2010).
Phospholipase A2 (PLA2)
We confirmed phospholipase in our cDNA library; its biochemical properties include 1137 AAs in position, molecular weight of 15320.45 Da, isoelectric point (pI) 7.92, pH range of 4
to 10, and a charge range of 12.37 to -18.89. These proteins are ubiquitous in nature; they
require Ca2+ for activity, they possess 6 conserved disulfide bonds with 1 or 2 variable disulfide
bonds (Burke and Dennis 2009), and they play a digestive role in hydrolysis of the sn-2 ester
bond of phospholipids (Six and Dennis 2000). Myotoxicity, neurotoxicity, and edema-inducing
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activities are the usual pharmacological effects of a snake bite (Fernandes et al. 2014). Some
PLA2s have been found to have apparent procoagulant activity (Armugam et al., 2004). Snake
populations with reasonable amounts of Type II venom tend to cause myonecrosis and spastic
hind-leg paralysis (Massy et al. 2012). Venom phospholipase A2 and mammalian phospholipase
A2 enzymes share similarities in both structure and catalytic function although venom PLA2s are
more toxic and have a wider range of pharmacological effects. PLA2 enzymes can bind to an
array of proteins and target various types of tissues and organs.
Serine Protease
We confirmed serine protease in our cDNA library; its biochemical properties include 11209 AAs in position, molecular weight of 22645.34 Da, isoelectric point (pI) 9.84, pH range of 4
to 10, and a charge range of 26.38 to -2.47. Serine proteases get their name because they have
essential serine residues present at their active sites; and they are sometimes referred to as
serine endopeptidases, they serve as nucleophilic amino acids at enzyme active sites and
function to split peptide bonds in proteins (Hedstrom 2002). Based on their structure, they are
divided in 2 categories: trypsin-like/chymotrypsin-like or subtilisin-like (Madala et al. 2010).
Trypsin-like serine proteases have specificity that is driven by negatively charged aspartic acid or
glutamic acid; they cut peptide bonds at amino acids that are positively charged such as lysine or
arginine (Evnin et al. 1990). Chymotrypsin-like proteases are more hydrophobic than trypsin-like
proteases. Subtilisin-like serine protease is found in prokaryotes, and they are known to produce
nucleophilic serine. For serine proteases, coagulation factor levels are necessary for the
diagnosis of hemorrhagic or thrombotic problems. They play major roles in extracellular
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proteolysis. Due to their long half-life, they stay in the human system for a clinically useful
length of time.
The 4 identified components of the full-length-enriched cDNA of timber rattlesnake (C.
horridus) venom have all shown application possibilities in pharmacology and medical sciences.
λTriplEx2 vectors were very instrumental in this study in producing these 4 components using
cell tissue culture. The various data bases—BLAST Blenching, Clustal Omega, ExPASy, and
RCSB—were very instrumental in retrieving the amino acid sequences and PDB files, getting
multiple sequence alignments, and also identifying their biochemical properties.
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CONCLUSION

We studied the components of timber rattlesnake (C. horridus) venom using modern
bioinformatics methods such as pre- and post-PCR techniques to further study and identify
snake venom components and determine their functions. Combining transcriptomics and
proteomics, we were able to identify the 4 components from our cDNA library; crotamine,
phospholipase A2, C-type lectin, and serine protease. λTriplEx2 vectors were very instrumental
in this study in producing these 4 components using cell tissue culture. We were able to
annotate the selected sequences with the venom-associated genes determining their
biochemical properties, coding regions, exons, introns, and functions. Gene expression levels for
the select genes were confirmed.
Crotamine functions to inhibit pain, and this means it can be a very effective analgesic. It
can be delivered to different cells because it forms a complex with plasmid DNA. Crotamine,
being a CPP makes it a suitable means for transporting macromolecules through the cell
membranes. Gene expression levels for crotamine was confirmed but showed no significant
different at between 0hr and 72hr (at p=.12). Proteins with C-type lectin possess functions such
as cell-to-cell adhesion, an immune response to pathogens, and apoptosis and have also shown
anticoagulant and procoagulant properties. PLA2 enzymes can bind to an array of proteins and
target various types of tissues and organs, and they tend to cause myonecrosis and spastic hindleg paralysis. Serine proteases play important roles in the diagnosis of hemorrhagic or
thrombotic problems, and they stay in the human system for a clinically useful length of time.
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The 4 identified components of the full-length-enriched cDNA of timber rattlesnake (C.
horridus) venom and their biochemical properties show promising applications in the fields of
pharmacology and medical sciences.
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APPENDIX A

Tables and Figures
Figure 9. Nucleotide sequences for selected venom components
a)

VG 4 – Crotamine

CGGCCGGAAAAATTTGGCCCAAAACCAGTCTCACCATGAAAATCCTTTATCTGCTGTTCGCTTTTCTTTTCC
TTGCTTTCCTGTCTGAACCAGGAAATGCCTATAAACGGGGTCTTAAAAAAGGAGGACCCTGTTTTCCCAA
AACCGAAATATGTCTTCCTCCATCTTCTGATTTTGGAAAAAGGGACTGTCAATGGAAAGGAAAATGCTGC
AAAAAGGAAAGGGAAAATAATGCCTTCCCCATCTAGGACCAGGGATATCTTCAAAATTTGGCCAAGGAC
CTGAAAGGGCCCCCTGCTATCCCTGTATCTTTCTTTAAAAAAAAAAAAAAAAA

b)

VG 36 – C-type lectin)

CGGCCGGAAAGCAGGGGTTTCACCGCAAAGGGGCCGAGGAAAAGGAAAGGAAAAAAAACCATGGGGG
GATTCTTCTTCGGGAGTTTTGGTTTGCTGGCCGGGTCCCTCTCCCTGAGGGAAACTGCAGCTGATTGCCCC
TCGGGTGGGTCTTCCTATGAAGGGCTTTGCTACAACCCCTTCAATGACCCAAAAACCGGGGATGATGCAA
AAAACTTCTGCCCACAACAGCACACAGGGGGACTTTTGGTCTCCTCCCACAGCACTGAAAAAGCAAATTT
TGGGAGCAAGCTGGCCTTCCAAACCTTTGGCCAAAGAATTTTCTGGATAGGACTGACCAATGTCTGGAAT
AAATGCACTTGGAAAGGGACCAAGGGGGCCTTGCTCAAATACAAAAACGGGGTTGAAAAATCTTATTGG
GTCTTTTTCAAGTCACCTAATAACAAATGGAGGAGTAAACCCTGCAAAATGTTGGCACATTTCGTCTGCG
AGTTCCGGGCATAATTTGAAAATGCGGTTGACCTGAAAAAATTCTGCAGAGGCAAGGAAGCCCCCCCCC
CCAGACCCCCCCACTTTGCTCAAGGGATGCTCTCTGGGGCGGAATCGGGTTCTGCGGCTCCGGAGGGAC
CAAAAGGTCCAATAAATTCTGCCTACCTTGAAAAAAAAAAAAAAAA
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c)

VG 141 – Phospholipase A2

CGGCCGGAAAGCAGGGGTATCAACGCAAAGTCATTACGGCCGGGGGCAGAGGAGCAAAGGGAGCCTG
CCAGGTGTGAATCTTTGCCATTTTCCCCTGCCTGGTTTCTCCTGATCCTTGCCTACAAATTATCCTTGACTTA
CAACCGTTTGTTTAGTGACCGTTCTAAGGGCCTTTTTCCAAACTTCACCAGCGGAGGCAATTAACGGGGT
CTGCTTATTCCCAAGTCTGGATTCGGGAGGATGAGGACTCTCTGGATAGGGGCCGTATTGCTGCTGGGC
GTCAAGGGGAGCCTGGGGCAATTTGAAATGATGATCATGGAAGGGGCGAAAAAAAGCGGTTTGCTTTG
GTACAGCGCTTACGGATGCTACTGCGGTTGGGGGGGCCATGGCCGGCCACAGGACGCCACTGACCGCT
GCTGCTTTGTGCACAACTGCTGTTACGGAAAAGCGACCGACTGCAACCCCAAAAGGGTCAGCTATACCTA
CAGCGAGGAAAACGGGGAATTCGTCTGCGGAGGGGACGACCCGTGCGGGACACAGATTTGTGAGTGCG
ACAAGGCCGCACCAATCTGCTTCCGAAACAATATACCCTCATACGACAACAAATATTGGCTGTTCCCGCCC
AAAATTGCCAGGAGGAACCAACCATGCTAAGTCTCTGCAGGCCGGGAAAAACCCCTCAAATTACACAATC
GTATTGGGTTACTCTATTATTCTGATGCATACTGAATAATAAACAGGTGCCACTTTTGCACTCAAAAAAAA
AAAAAAAAAA

d)

VG 172 – Serine protease

TTTCGGAAGGGCCCCTTGGTTTTGTTCCCGGGGATCCGCCCTTAGGGCGGGGGGGGAACTTCGGGATTC
ATTCTGCCAGTGTCCCAAATTGTTGGCCCCCCACCTGTTTATTTTGATCAAATAAAGGGCTGTTGGATCAA
AAAACCCCCGCTTGGTTTATCTAATAAAACTGATACGGAATCTCATTTTTAAGTTGGGAACGGGAATCTTA
CAAACAAACGGCTTACCGGGCAAAGCTGAAGTTATGGGGCTGATCAAAGGGCTACCAAACCTTCTGATA
CTACAGCTTTCTTACCCCCAAAATTCTTCTGACCTGGCCTTTGGAGGGGATAAATGTAACATAAATGAACT
TCGTCCCCTTGCCCCCGGGTATATCACTAAAGGTTTTCCCTGCCCTGGAACTTTGATCAACAAGAAAGGG
GGGCTGACCGCTGCCCCCTGCAACGGGGAAAATTTTCCCTTTTTACTCGGGGGGCTTACCCTAAGGGAAC
TAATTAAGGATGTGCAAAAAAAAGCCCCAAAGGAAAATTTCTTTTGTCCCATTAGGAAAAAAATTGATGA
AAAGGACAGGGACTTCTTGTTTATCAGGTTCAACAGCCCTGTTACCAGCAGTACACACTTCGCGCCTCTCA
GTTGGCCTTCCAACCCTCCCAGGGTGGGCCCAGTTTGCCGTATTATGGAAGGGGGCGCAATCCCACCCCC
AAAGGGGACTTTGCCCGGGGCCCCTCTTTTGGGTTACTTTAACATACTCAATTATAAGGGGGGTCAACCA
GCTTACGCAAGGTTGCCACAAACAAGAAAAAAATTGGGGTGCAGGATCCCGAAAAGAGGAAAAAGTTC
TTGTAAGGGGGACTCTGGGGGACCCCTCCTCTGAATGGAAAAATCCAGGGTATTGATCTGGGGGGGGA
AATTTTGGCCCAACCGGGAGACCTGTGCTTACCCAGGGCTCTATTTCCTGTTGGATCCAAATTTTTGGAGG
AATACAACGCACTGCCCCCATAAATTTCGAAAACTAAAAGAAAAATACACTCCTCTATTCCCAACCTTCCA
CTTCTTAAATTTAGCCCGATTTCTCCTACACAATATTATAAATGCGCCC
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Figure 10. Amino acid sequences for selected venom components

a) VG 4 – Crotamine
MKILYLLFAFLFLAFLSEPGNAYKRGLKKGGPCFPKTEICLPPSSDFGKRDCQWKGKCCKKERENNAFPI

b) VG 36 – C-type lectin (CLEC)
MGGFFFGSFGLLAGSLSLRETAADCPSGGSSYEGLCYNPFNDPKTGDDAKNFCPQQHTGGLLVSSHSTEKAN
FGSKLAFQTFGQRIFWIGLTNVWNKCTWKGTKGALLKYKNGVEKSYWVFFKSPNNKWRSKPCKMLAHFVC
EFRA

c) VG 141 – Phospholipase A2 (PLA2)
MRTLWIGAVLLLGVKGSLGQFEMMIMEGAKKSGLLWYSAYGCYCGWGGHGRPQDATDRCCFVHNCCYGK
ATDCNPKRVSYTYSEENGEFVCGGDDPCGTQICECDKAAPICFRNNIPSYDNKYWLFPPKIARRNQPC

d) VG 172 – Serine protease
MGLIKGLPNLLILQLSYPQNSSDLAFGGDKCNINELRPLAPGYITKGFPCPGTLINKKGGLTAAPCNGENFPFLL
GGLTLRELIKDVQKKAPKENFFCPIRKKIDEKDRDFLFIRFNSPVTSSTHFAPLSWPSNPPRVGPVCRIMEGGAI
PPPKGTLPGAPLLGYFNILNYKGGQPAYARLPQTRKKLGCRIPKRGKSSCKGDSGGPLL
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APPENDIX B
THESIS OPTION FORM
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APPENDIX C
PROSPECTUS FOR THESIS FORM
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